Orthopedics This Week
Get Ready for a 90-Day Corticosteroid
A new, extended release corticosteroid brand named Zilretta is in the final stages of FDA review. The FDA recently established a user fee goal for Zilretta of October 6, 2017. If met, then the first extended release corticosteroid will be on the market very soon. It will be, we think, a game changer.